Washington Post |
We're spending $107 billion on cancer drugs, but is it worth it?
Washington Post A flood of innovative cancer treatments helped fuel an 11.5 percent surge in spending on oncology drugs over the past year -- to $107 billion globally , according to a new report. But there's a crucial question the study can't quite answer: how much ... Global cancer drug spending to exceed $150 billion by 2020: IMS report The ever-escalating cost of cancer drugs Morning Read: Spending on oncology drugs rises 11.5% to $107B, NantHealth prices IPO |
from Health - Google News http://news.google.com/news/url?sa=t&fd=R&ct2=us&usg=AFQjCNHQgDpwazsEV5Oxcl4ARwQAqBzmYA&clid=c3a7d30bb8a4878e06b80cf16b898331&cid=52779125271186&ei=ZjFQV_jCMIKK3AGYj4LgDA&url=https://www.washingtonpost.com/news/wonk/wp/2016/06/02/were-spending-107-billion-on-cancer-drugs-but-is-it-worth-it/
via IFTTT
No comments:
Post a Comment